Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

HCV Genotype 6 Responds to 8-Week Oral Treatment

Editor's pick
MD
2 January 2018
Hepatitis C treatment

Should uninfected patients accept hepatitis C-infected livers to reduce waiting time?

Editor's pick
Eurekalert Inf Dis
20 December 2017
Hepatitis C treatment

MSF: People co-infected with HIV to receive hepatitis C treatment in Mykolaiv region

Editor's pick
UNIAN
4 December 2017
Hepatitis C treatment

Gilead prices hepatitis C giant Sovaldi in China at one-fifth the US price: report

Editor's pick
FiercePharma
29 November 2017
Hepatitis C treatment

Nine countries now on track to eliminate hepatitis

Editor's pick
World Hepatitis Summit
1 November 2017
Access to healthcare

MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug

Editor's pick
Intellectual Property Watch
31 October 2017
Hepatitis C treatment

Close to 3 million people access hepatitis C cure

Editor's pick
World Health Organization
31 October 2017
Pharmaceutical industry

Gilead HCV drug sales down in 2017 third quarter compared with 2016

Editor's pick
Healio
31 October 2017
Hepatitis C treatment

More than 6 million treated for hepatitis globally

Editor's pick
Healio
31 October 2017
Pharmaceutical industry

Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty

Editor's pick
Intellectual Property Watch
26 October 2017
Harm reduction

Screening for Hepatitis C Improves Opioid Abuse Treatment Outcomes

Editor's pick
AASLD
23 October 2017
Hepatitis C treatment

Egypt launches aggressive campaign to stamp out hepatitis C

Editor's pick
FRANCE 24
6 October 2017
UK health services

Hep C: An end in sight?

Editor's pick
Drink & Drug News
5 October 2017
Access to healthcare

Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment

Editor's pick
Kaiser Health News
5 October 2017
Pharmaceutical industry

The Hepatitis Drug Market Is Worse Than Wall Street Realises

Editor's pick
Bloomberg
4 October 2017
Hepatitis C treatment

VA models provide guidance for care of hepatitis C infection

Editor's pick
Medical Xpress
28 September 2017
Access to healthcare

No, there isn’t a hepatitis cure ‘for hipsters’ with a £35,000 price tag and own clothing line

Editor's pick
Metro
27 September 2017
Hepatitis C treatment

Injection drug users with HCV in Scotland lack awareness of DAA efficacy

Editor's pick
Healio
12 September 2017
Pharmaceutical industry

AbbVie Mavyret Price Threatens Gilead Hepatitis Dominance

Editor's pick
Bloomberg
7 August 2017
Hepatitis C treatment

Direct-acting antivirals successfully treating hepatitis C, says Public Health England

Editor's pick
Pharmaceutical Journal
2 August 2017
Hepatitis C treatment

Australia leads the world in hepatitis C treatment – what's behind its success?

Editor's pick
The Conversation AU
31 July 2017
Hepatitis C treatment

Substantial fall in Hepatitis C rates in Canberra's jail with new treatments

Editor's pick
The Canberra Times
31 July 2017
Hepatitis C treatment

Hepatitis C patients unable to get drugs due to funding problems

Editor's pick
Irish Times
31 July 2017
Hepatitis C treatment

From chronic to cured: could Australia be the first country in the world to eliminate hep C?

Editor's pick
Kirby Institute
28 July 2017